The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | EBF ENNIS, INC. | Boyne Wade Brewer Chief Operating Officer | CConversion Common Stock | +1,103 | $17.27 | $19k | 28,589 | 20 d ago |
| Sep 22, 2026 | EBF ENNIS, INC. | Boyne Wade Brewer Chief Operating Officer | CConversion ISO granted 4/21/2025 Right-to-Buyderivative | -1,103 | $17.27 | $19k | 0 | 20 d ago |
| Sep 22, 2026 | EBF ENNIS, INC. | Boyne Wade Brewer Chief Operating Officer | CConversion ISO granted 04/20/2026derivative | -2,000 | $19.76 | $40k | 1,603 | 20 d ago |
| Sep 21, 2026 | HOOD Robinhood Markets, Inc. | Vladimir Tenev Chief Executive Officer | CConversion Class A Common Stock10b5-1 | +259,166 | - | - | 259,166 | 20 d ago |
| Sep 21, 2026 | HOOD Robinhood Markets, Inc. | Vladimir Tenev Chief Executive Officer | CConversion Class B Common Stockderivative10b5-1 | -259,166 | $0.00 | $0 | 48,035,406 | 20 d ago |
| Sep 22, 2026 | PINS PINTEREST, INC. | Benjamin Silbermann director, owner | CConversion Class A Common Stockindirect: Benjamin and Divya Silbermann Family Trust10b5-1 | +46,875 | $0.00 | $0 | 46,875 | 20 d ago |
| Sep 23, 2026 | PINS PINTEREST, INC. | Benjamin Silbermann director, owner | CConversion Class A Common Stockindirect: Benjamin and Divya Silbermann Family Trust10b5-1 | +46,875 | $0.00 | $0 | 46,875 | 20 d ago |
| Sep 22, 2026 | PINS PINTEREST, INC. | Benjamin Silbermann director, owner | CConversion Class B Common Stockderivativeindirect: Benjamin and Divya Silbermann Family Trust10b5-1 | -46,875 | $0.00 | $0 | 34,377,513 | 20 d ago |
| Sep 23, 2026 | PINS PINTEREST, INC. | Benjamin Silbermann director, owner | CConversion Class B Common Stockderivativeindirect: Benjamin and Divya Silbermann Family Trust10b5-1 | -46,875 | $0.00 | $0 | 34,330,638 | 20 d ago |
| Sep 21, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class A Common Stock10b5-1 | +27,960 | $14.42 | $403k | 27,960 | 20 d ago |
| Sep 21, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class A Common Stock10b5-1 | +9,406 | $38.08 | $358k | 37,366 | 20 d ago |
| Sep 22, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class A Common Stock10b5-1 | +3,614 | $38.08 | $138k | 3,614 | 20 d ago |
| Sep 21, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class B Common Stockderivative10b5-1 | +27,960 | $0.00 | $0 | 3,396,080 | 20 d ago |
| Sep 21, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class B Common Stockderivative10b5-1 | -27,960 | $0.00 | $0 | 3,368,120 | 20 d ago |
| Sep 21, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class B Common Stockderivative10b5-1 | +9,406 | $0.00 | $0 | 3,377,526 | 20 d ago |
| Sep 21, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class B Common Stockderivative10b5-1 | -9,406 | $0.00 | $0 | 3,368,120 | 20 d ago |
| Sep 22, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class B Common Stockderivative10b5-1 | +3,614 | $0.00 | $0 | 3,371,734 | 20 d ago |
| Sep 22, 2026 | DUOL Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | CConversion Class B Common Stockderivative10b5-1 | -3,614 | $0.00 | $0 | 3,368,120 | 20 d ago |
| Sep 21, 2026 | DDOG Datadog, Inc. | David M Obstler Chief Financial Officer | CConversion Class A Common Stockindirect: By Trust10b5-1 | +3,000 | $0.00 | $0 | 3,000 | 20 d ago |
| Sep 21, 2026 | DDOG Datadog, Inc. | David M Obstler Chief Financial Officer | CConversion Class A Common Stockindirect: By Trust10b5-1 | +3,000 | $0.00 | $0 | 3,000 | 20 d ago |
| Sep 21, 2026 | DDOG Datadog, Inc. | David M Obstler Chief Financial Officer | CConversion Class B Common Stockderivativeindirect: By Trust10b5-1 | -3,000 | $0.00 | $0 | 31,198 | 20 d ago |
| Sep 21, 2026 | DDOG Datadog, Inc. | David M Obstler Chief Financial Officer | CConversion Class B Common Stockderivativeindirect: By Trust10b5-1 | -3,000 | $0.00 | $0 | 31,199 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Carl L Gordon director, owner | CConversion Common Stockindirect: See footnotes | +2,002,310 | - | - | 2,002,310 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Carl L Gordon director, owner | CConversion Common Stockindirect: See footnotes | +1,087,934 | - | - | 3,090,244 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Carl L Gordon director, owner | CConversion Common Stockindirect: See footnotes | +1,703,314 | - | - | 4,793,558 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Carl L Gordon director, owner | CConversion Common Stockindirect: See footnotes | +758,279 | - | - | 758,279 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Carl L Gordon director, owner | CConversion Series A Convertible Preferred Stockderivativeindirect: See footnotes | -2,002,310 | $0.00 | $0 | 0 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Carl L Gordon director, owner | CConversion Series B Convertible Preferred Stockderivativeindirect: See footnotes | -1,087,934 | $0.00 | $0 | 0 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Carl L Gordon director, owner | CConversion Series C Convertible Preferred Stockderivativeindirect: See footnotes | -1,703,314 | $0.00 | $0 | 0 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Carl L Gordon director, owner | CConversion Series C Convertible Preferred Stockderivativeindirect: See footnotes | -758,279 | $0.00 | $0 | 0 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Orbimed Advisors LLC director, owner | CConversion Common Stockindirect: See footnotes | +2,002,310 | - | - | 2,002,310 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Orbimed Advisors LLC director, owner | CConversion Common Stockindirect: See footnotes | +1,087,934 | - | - | 3,090,244 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Orbimed Advisors LLC director, owner | CConversion Common Stockindirect: See footnotes | +1,703,314 | - | - | 4,793,558 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Orbimed Advisors LLC director, owner | CConversion Common Stockindirect: See footnotes | +758,279 | - | - | 758,279 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Orbimed Advisors LLC director, owner | CConversion Series A Convertible Preferred Stockderivativeindirect: See footnotes | -2,002,310 | $0.00 | $0 | 0 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Orbimed Advisors LLC director, owner | CConversion Series B Convertible Preferred Stockderivativeindirect: See footnotes | -1,087,934 | $0.00 | $0 | 0 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Orbimed Advisors LLC director, owner | CConversion Series C Convertible Preferred Stockderivativeindirect: See footnotes | -1,703,314 | $0.00 | $0 | 0 | 20 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Orbimed Advisors LLC director, owner | CConversion Series C Convertible Preferred Stockderivativeindirect: See footnotes | -758,279 | $0.00 | $0 | 0 | 20 d ago |
| Sep 21, 2026 | AUGO Aura Minerals Inc. | Mauad Bruno Sousa director | CConversion Common Sharesindirect: By Kapitalo Investimentos | +1,600 | $87.39 | $140k | 136,041 | 21 d ago |
| Sep 21, 2026 | AUGO Aura Minerals Inc. | Mauad Bruno Sousa director | CConversion Brazilian Depositary Receiptsderivativeindirect: By Kapitalo Investimentos | -4,800 | $29.15 | $140k | 12,743,176 | 21 d ago |
| Sep 21, 2026 | GPCR Structure Therapeutics Inc. | Crespo Blas Coll CHIEF MEDICAL OFFICER | CConversion Ordinary Shares10b5-1 | -12,024 | $0.00 | $0 | 258,228 | 21 d ago |
| Sep 21, 2026 | GPCR Structure Therapeutics Inc. | Crespo Blas Coll CHIEF MEDICAL OFFICER | CConversion American Depositary Sharesderivative10b5-1 | +4,008 | $0.00 | $0 | 5,165 | 21 d ago |
| Sep 18, 2026 | CRWV CoreWeave, Inc. | Brian M Venturo Chief Strategy Officer | CConversion Class A Common Stock | +62,500 | - | - | 303,871 | 21 d ago |
| Sep 18, 2026 | CRWV CoreWeave, Inc. | Brian M Venturo Chief Strategy Officer | CConversion Class B Common Stockderivativeindirect: Venturo Family 2024 Friends and Family GRAT Remainder Trust | -62,500 | - | - | 1,515,849 | 21 d ago |
| Sep 18, 2026 | BIRD Smartbird, Inc. | Richard W Boyce director | CConversion Class A Common Stockindirect: By Trust | +48,277 | - | - | 48,277 | 21 d ago |
| Sep 18, 2026 | BIRD Smartbird, Inc. | Richard W Boyce director | CConversion Class B Commonderivativeindirect: By Trust | -48,277 | - | - | 5,589 | 21 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Graham Parry Chief Scientific Officer | CConversion Common Stock | +85,504 | - | - | 85,504 | 22 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Graham Parry Chief Scientific Officer | CConversion Series A Convertible Preferred Stockderivative | -85,504 | - | - | 0 | 22 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Gary S. Koe Chief Technical Officer | CConversion Common Stock | +63,656 | - | - | 63,656 | 22 d ago |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Gary S. Koe Chief Technical Officer | CConversion Series A Convertible Preferred Stockderivative | -63,656 | - | - | 0 | 22 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.